Utama › Dermatitis Atopik (Eksim) › Florida

Kajian klinikal Dermatitis Atopik (Eksim) di Florida

18 kajian untuk Dermatitis Atopik (Eksim) sedang mencari peserta di lokasi di Florida.

Bandar di Florida

Teks kajian rasmi (Bahasa Inggeris)

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

Clinical Site 110, Miami

Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan

Umur 18 hingga 65 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07453602

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

St. Jude Clinical Research- Site Number : 8400049, Doral
Ziaderm Research, LLC- Site Number : 8400021, North Miami Beach

Mengambil pesertaKajian pemerhatian

Umur 12 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07290803

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

Novartis Investigative Site, Miami
Novartis Investigative Site, St. Petersburg

Mengambil pesertaFasa 2

Umur 18 hingga 100 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06947993

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Enveda Investigative Site, Fort Lauderdale
Enveda Investigative Site, Miami
Enveda Investigative Site, Miramar

Mengambil pesertaFasa 2

Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07298395

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Solutions Through Advanced Research, Jacksonville

Mengambil pesertaFasa 3

Umur 2 hingga 11 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06807281

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

Gsi Clinical Research, Margate

Mengambil pesertaFasa 2

Umur 18 hingga 64 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07216027

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

Investigational Site, Coral Gables
Investigational Site, Jacksonville
Investigational Site, Margate

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07003425

A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

Olympian Clinical Research, Tampa

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07223697

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

AllerVie Clinical Research, Panama City
GCP Research , Global Clinical Professionals, St. Petersburg

Mengambil pesertaFasa 3

Umur 12 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07765888

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

ABMED Clinical Research Corp., Cape Coral
Skin Care Research, Hollywood
Quality Care Clinical Research, Miami
dan 4 lagi

Mengambil pesertaFasa 2

Umur 18 hingga 65 · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07599813

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Inmagene Site 19, Ocala
Inmagene Site 4, Tampa

Mengambil pesertaFasa 2

Umur 18 hingga 74 · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT07037901

A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Enveda Investigative Site, Boca Raton

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT07643766

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Pediatric Skin Research - Coral Gables /ID# 266308, Coral Gables

Mengambil pesertaFasa 3

Umur 2 hingga 11 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT06461897

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Miami Dermatology and Laser Research, Miami

Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan

Umur 18 hingga 70 · Semua jantina · Dikemas kini 22 Jul 2026 · NCT06564389

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Leo Pharma Investigational site, Jacksonville
Leo Pharma Investigational site, Miami
Leo Pharma Investigational site, Tampa

Mengambil pesertaFasa 3

6 Months – 11 Years · Semua jantina · Dikemas kini 7 Jul 2026 · NCT06311682

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Skin Care Research Boca Raton /ID# 263733, Boca Raton
TrueBlue Clinical Research - Brandon /ID# 265037, Brandon
Life Clinical Trials - Coral Springs /ID# 267195, Coral Springs
dan 13 lagi

Mengambil pesertaFasa 3

Umur 18 hingga 63 · Semua jantina · Dikemas kini 6 Jul 2026 · NCT06389136

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

Revival Research, Doral
Floridian Research Institute Llc, Miami
Global Health Research Center, Inc., Miami Lakes
dan 4 lagi

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 4 Mei 2026 · NCT05995964

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Galderma Investigational Site 8597, Boca Raton
Galderma Investigational Site 7087, Coral Gables
Galderma Investigational Site 7063, Cutler Bay
dan 7 lagi

Mengambil pesertaKajian pemerhatian

Umur 12 ke atas · Semua jantina · Dikemas kini 13 Mac 2026 · NCT06988605

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.